These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3829216)

  • 1. [Reactions to vaccination against yellow fever].
    Pivetaud JP; Raccurt CP; M'Bailara L; Le Vigouroux A; Le Bras M
    Bull Soc Pathol Exot Filiales; 1986; 79(5 Pt 2):772-6. PubMed ID: 3829216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leads from the MMWR. Yellow fever vaccine.
    JAMA; 1984 Jan; 251(4):442-3. PubMed ID: 6690805
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefit versus risk factors in immunization against yellow fever.
    Brès P
    Dev Biol Stand; 1979; 43():297-304. PubMed ID: 574841
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of the yellow Fever vaccine: a retrospective study.
    Nordin JD; Parker ED; Vazquez-Benitez G; Kharbanda EO; Naleway A; Marcy SM; Molitor B; Kuckler L; Baggs J
    J Travel Med; 2013; 20(6):368-73. PubMed ID: 24118538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yellow fever vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jan; 32(52):679-82, 687-8. PubMed ID: 6419048
    [No Abstract]   [Full Text] [Related]  

  • 6. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe post-vaccination reaction to 17D yellow fever vaccine in Nigeria.
    Oyelami SA; Olaleye OD; Oyejide CO; Omilabu SA; Fatunla BA
    Rev Roum Virol; 1994; 45(1-2):25-30. PubMed ID: 7756161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of stabilized yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983].
    Saluzzo JF; Some L; Baudon D; Girault G; Lhuillier M; Kambire PA; Roux JF; Digoutte JP
    Bull Soc Pathol Exot Filiales; 1985; 78(4):536-40. PubMed ID: 4075474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relevant vaccination for travellers].
    Rieke B
    MMW Fortschr Med; 2003 Nov; 145(45):30-1. PubMed ID: 14699803
    [No Abstract]   [Full Text] [Related]  

  • 10. [Yellow fever: desensitization to an anti-amaril 17 D vaccine performed on a patient with anaphylaxis to eggs].
    Charpin J; Vervloet D; Birnbaum J; Tafforeau M; Sentissi S
    Bull Acad Natl Med; 1987 Nov; 171(8):1001-5. PubMed ID: 3329939
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution to the study of vaccinal reactions observed outside Dakar].
    Sankalé M; Bourgeade A; Wade F; Bèye B
    Bull Soc Med Afr Noire Lang Fr; 1966; 11(3):617-23. PubMed ID: 4382459
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.
    Belmusto-Worn VE; Sanchez JL; McCarthy K; Nichols R; Bautista CT; Magill AJ; Pastor-Cauna G; Echevarria C; Laguna-Torres VA; Samame BK; Baldeon ME; Burans JP; Olson JG; Bedford P; Kitchener S; Monath TP
    Am J Trop Med Hyg; 2005 Feb; 72(2):189-97. PubMed ID: 15741556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field trial of combined yellow fever and measles vaccines among children in Nigeria.
    Adu FD; Omotade OO; Oyedele OI; Ikusika O; Odemuyiwa SO; Onoja AL
    East Afr Med J; 1996 Sep; 73(9):579-82. PubMed ID: 8991237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever vaccination.
    Middleton D
    Lancet; 1999 Jan; 353(9147):154. PubMed ID: 10023934
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemic of yellow fever in the southeastern region of Upper Volta (October-December, 1983). Epidemiological study. Preliminary results].
    Roux J; Baudon D; Robert V; Stanghellini A; Gazin P; Lhuillier M; Saluzzo JF; Cornet M; Sarthou JL; Molez JF
    Med Trop (Mars); 1984; 44(4):303-9. PubMed ID: 6542965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
    Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
    Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever vaccine. Recommendations of the Immunization Practices Advisory Committee (ACIP).
    MMWR Recomm Rep; 1990 May; 39(RR-6):1-6. PubMed ID: 2159593
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new combined vaccine against yellow fever and measles in infants aged 6 to 24 months in Mali].
    Soula G; Sylla A; Pichard E; Kodio B; Bentejac MC; Teulières L; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):885-97. PubMed ID: 1819436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inactivated cell-culture vaccine against yellow fever.
    Monath TP; Fowler E; Johnson CT; Balser J; Morin MJ; Sisti M; Trent DW
    N Engl J Med; 2011 Apr; 364(14):1326-33. PubMed ID: 21470010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The combined measles-yellow fever vaccination in African infants aged 6 to 10 months].
    Mouchon D; Pignon D; Vicens R; Tu-Ha-Thanh ; Tekaia F; Teulières L; Garrigue G
    Bull Soc Pathol Exot; 1990; 83(4):537-51. PubMed ID: 2286007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.